Skip to main content

THERAPEUTIC TRIAL FOR DOGS WITH BLADDER CANCER

Principle Investigator

Claire Amanda Wiley

Description

Double-blinded therapeutic trial for dogs with a diagnosis of bladder cancer. This study will provide a nutritional supplement or placebo as an additional treatment for dogs currently receiving chemotherapy for their bladder cancer. The goal of this study is to determine if adding this dietary supplemental to standard of care bladder cancer therapy improves survival.

Testing Requirements

To participate, you will be asked to:
– Supplement your dog’s food once per day with a supplement
– Follow up with designated veterinary clinic for continued treatment with chemotherapy
– Collect a urine sample from your dog monthly for up to 12 months

Enrollment Start

03/01/2022

Enrollment Finish

01/01/2023

Eligibility

To qualify, your dog must have:
– A diagnosis of bladder cancer (UC) via cytology or biopsy within the past 6 weeks
– A measurable mass in the bladder visible on ultrasound in the past 6 weeks
– Detectable BRAF mutation in the urine in the past 6 weeks
– Treatment with chemotherapy (typically mitoxantrone and piroxicam)

Flyer

View

Contact

Claire Wiley: UCClinicalTrials@ncsu.edu